MGNX
MacroGenics Inc
Price:  
4.63 
USD
Volume:  
1,593,777.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MGNX EV/EBITDA

-1262.1%
Upside

As of 2024-05-24, the EV/EBITDA ratio of MacroGenics Inc (MGNX) is -1.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MGNX's latest enterprise value is 209.30 mil USD. MGNX's TTM EBITDA according to its financial statements is -163.72 mil USD. Dividing these 2 quantities gives us the above MGNX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 15.8x - 22.4x 19.8x
Forward P/E multiples 20.0x - 23.8x 22.4x
Fair Price (51.11) - (57.29) (53.80)
Upside -1203.9% - -1337.3% -1262.1%
4.63 USD
Stock Price
(53.80) USD
Fair Price

MGNX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-23 -1.28
2024-05-22 -1.31
2024-05-21 -1.14
2024-05-20 -1.14
2024-05-17 -1.18
2024-05-16 -1.47
2024-05-15 -1.31
2024-05-14 -1.21
2024-05-13 -1.18
2024-05-10 -0.77
2024-05-09 -5.11
2024-05-08 -5.11
2024-05-07 -5.64
2024-05-06 -5.76
2024-05-03 -5.50
2024-05-02 -5.32
2024-05-01 -5.45
2024-04-30 -5.16
2024-04-29 -5.17
2024-04-26 -5.07
2024-04-25 -5.00
2024-04-24 -5.51
2024-04-23 -5.71
2024-04-22 -5.40
2024-04-19 -5.47
2024-04-18 -5.65
2024-04-17 -5.66
2024-04-16 -5.88
2024-04-15 -5.98
2024-04-12 -6.21
2024-04-11 -6.58
2024-04-10 -6.48
2024-04-09 -6.43
2024-04-08 -6.52
2024-04-05 -6.48
2024-04-04 -6.30
2024-04-03 -4.73
2024-04-02 -4.60
2024-04-01 -4.87
2024-03-28 -5.13
2024-03-27 -5.23
2024-03-26 -4.94
2024-03-25 -5.02
2024-03-22 -5.04
2024-03-21 -5.39
2024-03-20 -5.39
2024-03-19 -5.46
2024-03-18 -5.47
2024-03-15 -5.60
2024-03-14 -5.65